Serve You Rx Transitions Ownership Of Overdose Aid Kit (OAK) Program To The Clinton Foundation For National Scaling 

PRESS RELEASE • AUG 19, 2023 11:00 AM EDT  MILWAUKEE, Wisc. (Newswire.com) - In a significant move to combat the ongoing opioid epidemic that has ravaged communities across the United States, Serve You Rx announced the transition of ownership of its life-saving Overdose Aid Kit (OAK) program to the Clinton Foundation. This transition was unveiled during a press…

Read More

A New Era for Humira® Biosimilars: The Interchangeable Revolution 

"A new era for Humira biosimilars is an Interchangeable Revolution" - article title in yellow, blue, and green overtop a needle, representing the drug Humira. Humira is an injectable medication.

The release of interchangeable Humira biosimilars is increasing accessibility to effective rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis treatments while reducing costs.   This is a win-win situation for patients, healthcare providers, and payers, as pricing for these products falls due to increasing competition from biosimilars.   The Rise of Interchangeable Humira Biosimilars…

Read More

Unlocking the Power of the Real-Time Benefit Check

"Unlocking the Power of the Real-time Benefit Check" - article title with an image of a happy pharmacist. The pharmacist is happy because they are able to check benefits before filling a prescription, saving everyone time and saving the patient money.

One source of fear associated with visiting a doctor is the financial consequences. That’s where ConfirmRx comes in. With newly prescribed medicines, the patient often leaves the office not knowing the cost of their prescription, whether a preferred alternative is available, or if the physician needs to provide additional information before they can pick it…

Read More

Humira Users: Help is on the Way

Always on the cutting edge, Serve You Rx plans to offer up to three new Humira biosimilars this calendar year. Amgen’s Amjevita upcoming launch leads the list of upcoming biosimilar versions of AbbVie’s Humira, which has long been a dynamic medical and financial success.  “We’re extremely pleased about the upcoming availability of Humira biosimilars for…

Read More